pyridostigmine bromide has been researched along with Pituitary Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borges, MH; Castro, RC; Kater, CE; Lengyel, AM | 1 |
| Bieglmayer, C; Nardi, A; Vierhapper, H | 1 |
| Bossoni, S; Buffoli, MG; Ferrari, C; Giustina, A; Pozzi, A; Scalvini, T; Schettino, M | 1 |
| Bodini, C; Bossoni, S; Ferrari, C; Giustina, A; Pizzocolo, G; Scalvini, T; Schettino, M; Wehrenberg, WB | 1 |
1 trial(s) available for pyridostigmine bromide and Pituitary Neoplasms
| Article | Year |
|---|---|
Pyridostigmine enhances even if it does not normalize the growth hormone responses to growth hormone-releasing hormone in patients with Cushing's disease.
Topics: Adenoma; Administration, Oral; Adult; Antibodies, Monoclonal; Cushing Syndrome; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Injections, Intravenous; Pituitary Neoplasms; Pyridostigmine Bromide; Radioimmunoassay | 1991 |
3 other study(ies) available for pyridostigmine bromide and Pituitary Neoplasms
| Article | Year |
|---|---|
Different effects of pyridostigmine on growth hormone (GH) response to GH-releasing hormone in endogenous and exogenous hypercortisolemic patients.
Topics: Adolescent; Adrenocortical Adenoma; Adult; Cushing Syndrome; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hydrocortisone; Lupus Erythematosus, Systemic; Male; Pituitary Neoplasms; Pyridostigmine Bromide; Somatostatin; Time Factors | 1993 |
The use of the pyridostigmine growth hormone-releasing hormone stimulation test to detect growth hormone deficiency in patients with pituitary adenomas.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Aging; Body Mass Index; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Pyridostigmine Bromide | 2002 |
Effect of pretreatment with pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in patients with Cushing's disease.
Topics: Adenoma; Adult; Cushing Syndrome; Drug Interactions; Female; Humans; Middle Aged; Pituitary Neoplasms; Pyridostigmine Bromide; Radioimmunoassay; Thyrotropin; Thyrotropin-Releasing Hormone | 1992 |